- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00759187
Evaluate Clinical Research From Commerical Oral Care Products
February 24, 2010 updated by: Colgate Palmolive
The purpose of this study is to conduct a clinical study comparing anti-plaque efficacy of commercial oral care products.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to compare efficacy of two commercially available toothpastes and one oral rinse on dental plaque control.
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston University School of Dental Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 63 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female volunteers 18-65 years of age
- Good general health
- Must sign informed consent form
- Minimum of 20 natural uncrowned teeth (excluding third molars) must be present.
- No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.
Exclusion Criteria:
- Subjects unable or unwilling to sign the informed consent form.
- Medical condition which requires pre-medication prior to dental visits/procedures
- Moderate or advanced periodontal disease or heavy dental tartar (calculus) requiring more than one visit of cleaning sessions
- 2 or more decayed untreated dental sites at screening.
- Other disease of the hard or soft oral tissues.
- Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation).
- Use of medications that can currently affect salivary flow.
- Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1.
- Pregnant or nursing women.
- Participation in any other clinical study within 1 week prior to enrollment into this study.
- Allergy to chlorhexidine
- Use of tobacco products
- Subjects who must receive dental treatment during the study dates.
- Current use of Antibiotics for any purpose.
- Presence of an orthodontic appliance.
- History of allergy to common dentifrice ingredients.
- Immune compromised individuals (HIV, AIDS, immuno suppressive drug therapy)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: B
|
Half mouth toothbrushing twice daily for 4 days
Other Names:
|
Active Comparator: C
|
Mouth rinsing twice a day for 4 days
Other Names:
|
Placebo Comparator: A
|
Brush twice daily
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dental Plaque Index
Time Frame: 4-Day
|
Scale 0 to 5 (zero= no plaque to 5 = plaque covering 2/3 or more of the crown of the tooth)
|
4-Day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Thomas Van Dyke, DDS
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (Actual)
April 1, 2008
Study Completion (Actual)
April 1, 2008
Study Registration Dates
First Submitted
September 23, 2008
First Submitted That Met QC Criteria
September 23, 2008
First Posted (Estimate)
September 25, 2008
Study Record Updates
Last Update Posted (Estimate)
March 4, 2010
Last Update Submitted That Met QC Criteria
February 24, 2010
Last Verified
November 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Stomatognathic Diseases
- Periodontal Diseases
- Mouth Diseases
- Gingival Diseases
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents, Local
- Anti-Infective Agents
- Antimetabolites
- Protective Agents
- Dermatologic Agents
- Hypolipidemic Agents
- Lipid Regulating Agents
- Cariostatic Agents
- Disinfectants
- Fatty Acid Synthesis Inhibitors
- Fluorides
- Sodium Fluoride
- Chlorhexidine
- Chlorhexidine gluconate
- Fluorophosphate
- Triclosan
Other Study ID Numbers
- CRO-0607-PLA-11-RR
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gingival Diseases
-
Tokat Gaziosmanpasa UniversityCompletedGingival Recession | Gingival EnlargementTurkey
-
Tokat Gaziosmanpasa UniversityCompletedGingival EnlargementTurkey
-
Alexandria UniversityCompletedGingival EnlargementEgypt
-
University of BaghdadRecruitingThickening; GingivalIraq
-
Tokat Gaziosmanpasa UniversityCompleted
-
The University of Hong KongUnknown
-
University of Padova, School of Dental MedicineCompletedGingival Recession | Gingival Bleeding | Gingival DiseaseItaly
-
Semmelweis UniversityRecruitingRecurrence | Periodontal; Lesion | Localized Gingival Enlargement | EpulidesHungary
-
Inonu UniversityCompletedWound Heal | Gingival Enlargement | Gingival Overgrowth | Platelet Rich FibrinTurkey
-
Cairo UniversityUnknownGingival Thickness | Gingival Biotype | Periodontal Probe
Clinical Trials on Fluoride
-
GlaxoSmithKlineCompletedOral HygieneUnited States
-
Procter and GambleCompleted
-
Khon Kaen UniversityCompletedQuality of Life | Dental Caries in Children | Satisfaction | Oral Health | Cost EffectivenessThailand
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloUnknown
-
University of MichiganEnrolling by invitationDental CariesUnited States
-
Advantage Dental Services, LLCCompleted
-
GlaxoSmithKlineCompleted
-
Frank LippertThe Borrow FoundationCompleted
-
Federal University of ParaíbaConselho Nacional de Desenvolvimento Científico e Tecnológico; Coordination...Completed
-
GlaxoSmithKlineCompleted